UNSPSC 51333415: Ziprasidone hydrochloride monohydrate

Commodity

Code facts

NIGP codes
1

UNSPSC codes and definitions come from the UN Development Programme (managed by GS1 US), and state and local contract opportunities from the governments' procurement sites.

NIGP codes for 51333415

Definition

This classification denotes an antipsychotic agent with the molecular formula C21H21ClN4OS.ClH.H2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 216X081ORU, chemically known as 5-(2-(4-(1,2-benzisothiazol-3-yl)-1-piperazinyl)ethyl)-6-chloro-2-indolinone monohydrochloride, monohydrate but more generally known as ziprasidone hydrochloride, which bears US NIH Compound Identifier 60853.

European Medicines Agency schedules Ziprasidone hydrochloride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05189MIG. Most nations, for tariff and trade purposes, schedule ziprasidone hydrochloride monohydrate under HS 29341000. SMILES: C1CCC2C(C1)C(NS2)N3CCN(CC3)CCC4CC5C(CC4CL)NC(=O)C5.O.CL.

About UNSPSC 51333415

UNSPSC 51333415 Ziprasidone hydrochloride monohydrate is a Commodity code that nominally identifies a specific antipsychotic pharmaceutical product, but recent state and local solicitation activity under this code shows minimal relevant procurement volume. The single recent opportunity posted does not align with the code's pharmaceutical scope: Seminole County, Florida issued IFB 60459723LAS in June 2026 seeking Naloxone and Safe Drug Deactivation Systems—opioid-overdose reversal agents and drug disposal equipment—rather than the antipsychotic medication the code nominally describes. This mismatch suggests either miscoding at the issuing office or that the code is used inconsistently in state and local procurement systems.

The Seminole County opportunity represents the only recent activity visible under this code and does not reflect core ziprasidone procurement. Seminole County's IFB called for 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida; response deadline was July 26, 2023, with a two-year initial term and one-year renewal option. Vendors were required to provide electronic bids through the county e-procurement portal, include all shipping and delivery costs, maintain E-Verify compliance and drug-free workplace certification, and carry commercial general liability and workers' compensation insurance. The contract included a three-month probationary period and potential FEMA funding with associated federal compliance requirements. Business development professionals should verify with issuing offices whether solicitations tagged to this code represent actual pharmaceutical procurements or reflect upstream coding errors, as activity under the nominal scope of ziprasidone hydrochloride monohydrate appears limited in recent state and local markets.

Quick answers

What is UNSPSC 51333415?

UNSPSC 51333415 is Ziprasidone hydrochloride monohydrate, a commodity in UNSPSC 51000000, Pharmaceutical Products incl. Contraceptives and Vaccines.

Which NIGP codes match UNSPSC 51333415?

UNSPSC 51333415 maps to 1 NIGP code, 26928 Central Nervous System Agents (Including: Analegsic, Anticonvulsant, Antidepressant, Antihistamine, Antipsychotic and Sedative).

On GovTribe

See everything under UNSPSC 51333415

  • State & local contract opportunities, awards and contract vehicles under this code
  • Contacts who buy under this code
  • Ask GovTribe AI about this code